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A factor inducing differentiation of mouse myeloid leukemic cells (M 1) into macrophages was purified to 
apparent homogeneity from 168 1 of CM of Ehrlich ascites tumor cells. The purified factor was half-maxi- 
mally active at 2 x lo-ii M. The factor was analyzed by radioiodination, SDS-polyacrylamide gel electro- 
phoresis and autoradiography. Its M,was 4000~50000. On reduction, the factor lost activity, but showed 
no subunit structure. Treatment of the factor with endo-/?-N-acetylglucosaminidase F, but not endo-B-N- 
acetylglucosaminidase H, gave rise to a molecule of M,20000-28000. The activity of the factor from Ehrlich 
cells was completely neutralized by antiserum to the factor of M, 5OOO(r70000 from mouse tibroblast L929 
cells. 
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1. INTRODUCTION 
Mouse myeloid leukemic Ml cells can be in- 
duced to differentiate into macrophages by protein 
inducers (D-factors) and various chemicals [l-3]. 
On differentiation, Ml cells express a wide variety 
of morphological, biochemical and functional 
characteristics of normal macrophages, such as 
phagocytic and locomotive activities, lysosomal 
enzyme activities, Fc and C3 receptors and pro- 
staglandin production. Untreated Ml cells are 
leukemogenic in syngeneic mice, but on differen- 
tiation Ml cells lose their leukemogenicity. Injec- 
tion of D-factor, also named MGI-2, into mice in- 
oculated with Ml cells inhibited the proliferation 
of the leukemic cells in the bone marrow and pro- 
longed the survival of the mice [4]. Therefore, D- 
factors are possibly important for suppressing 
development of myeloid leukemia and may be 
useful for therapy of leukemia [2,3]. 
Abbreviations: D-factor, differentiation-inducing fac- 
tor; MGI, macrophage and granulocyte inducer; M-, G- 
and GM-CSF, macrophage, granulocyte and granulo- 
cyte-macrophage colony-stimulating factors, respective- 
ly; HPLC, high-performance liquid chromatography; 
CM, conditioned medium 
Although D-factor is thought to be produced in 
vivo mainly by activated macrophages and lym- 
phocytes [5], it is also produced spontaneously in 
vitro by some established cells. We [6] reported a 
procedure for purification of a D-factor of M, 
62 000 from CM of mouse fibroblast L929 cells and 
suggested that the D-factor is distinct from CSF, 
the growth factor for normal precursors of 
macrophages and/or granulocytes. However, fur- 
ther studies on this factor were difficult because L 
cells produced very little D-factor and the yield of 
purified D-factor was low. 
Here, we report the purification of a D-factor of 
M, 40000-50000 from a more readily available 
source, CM of Ehrlich ascites tumor cells, and 
discuss the relation between the two D-factors of 
different sizes. 
Published by Elsevier Science Publishers B. V. 
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2. MATERIALS AND METHODS 2.5. Iodination of D-factor 
2.1. Assay of D-factor 
D-Factor was assayed by measuring induction of 
phagocytic activity in Ml cells (clone T-22) as in 
[7], since induction of phagocytic activity in the 
cells was associated with the inductions of other 
phenotypic markers of cell differentiation, such as 
morphological differentiation and lysozyme activi- 
ty. Ml cells (5 x lo5 cells) were incubated for 2 
days in 1 ml of Eagle’s minimal essential medium 
containing D-factor, and then for 4 h with a 
suspension of polystyrene latex particles. Induc- 
tion of phagocytic cells was proportional to the 
concentration of D-factor. Fifty units of D-factor 
was defined as the activity inducing phagocytic ac- 
tivity in 50% of the cells under these conditions. 
Purified D-factor was iodinated as in [8,9]. Ali- 
quots of D-factor from the TSK G3OOOSW column 
were dried under vacuum in a Speed Vat unit. 
Then the preparation was mixed first with 10 /rl of 
0.2 M sodium phosphate buffer, pH 6.5, contain- 
ing 0.04% (w/v) polyethylene glycol 6000 and 
10 ~1 of 50% (v/v) dimethyl sulfoxide then with 
10 ~1 of carrier-free “‘I(1 mCi, Amersham Japan, 
Tokyo) and finally with 10~1 of a solution of 
chloramine T (200 pg/ml). The mixture was stood 
at 0°C for 30 min and then 10 ~1 of sodium 
metabisulfite (200 pg/ml) and 10 ~1 of 0.1 M KI 
were added. The iodinated D-factor was separated 
from unbound r*‘I by chromatography on an 
Ultrogel AcA 44 column in phosphate-buffered 
saline. 
2.2. Preparation of CM of Ehrlich ascites tumor 
2.6. SDS-polyacrylamide gel electrophoresis 
cells 
Ehrlich ascites tumor cells were passaged in ICR 
mice by intraperitoneal inoculation of about 10’ 
cells. The cells were harvested from the peritoneal 
cavity after 9 days, washed 3 times with phosphate- 
buffered saline and seeded at lo6 cells/ml in spin- 
ner flasks containing 8 1 of serum-free Eagle’s 
medium. After incubation for 2 days at 37”C, the 
culture fluid was collected and centrifuged (10000 
x g, 20 min) to remove cells and cell debris. 
The 1251-labeled D-factor was subjected to elec- 
trophoresis on 12% acrylamide slab gels (100 mm 
long, 140 mm wide, 1.5 mm thick) as in [lo], at a 
constant current of 30 mA for 3 h. Autoradio- 
graphy was performed at - 70°C for 1 day with X- 
Omat RP film (Kodak) and intensifying screens 
(DuPont Cronex HI Plus). The distribution of D- 
factor activity on the gel was examined in the 
absence of 2-mercaptoethanol. The activity was 
eluted from sections of the gel as in [l I]. 
2.7. Endoglycosidase treatment 
2.3. Purification procedures 
Volumes of 24 or 32 1 of CM of Ehrlich ascites 
tumor cells were concentrated to 2 1 with an 
Amicon HlOPlO hollow fiber and then to 200 ml 
with an HlPlO hollow fiber. Thereafter, D-factor 
was purified essentially as in [6], but the Sephadex 
G-200 column was replaced by an Ultrogel AcA 44 
column (LKB-Produkter AB, Stockholm). 
2.4. Protein determination 
Protein in fractions before the second HPLC 
step was determined by the dye fixation method 
(Bio-Rad Laboratories) with bovine serum 
albumin as a standard. Since the protein content of 
fractions after the second HPLC step was low, it 
was determined from the absorbance profile 
assuming that 1 mg protein/ml had an average ab- 
sorbance of 1 at 280 nm. 
Endo-P-N-acetylglucosaminidase F (EC 3.2.1) 
from F. meningosepticum and endo-P-N- 
acetylglucosaminidase H (EC 3.2.1.96) from S. 
plicatus were purchased from New England 
Nuclear, Boston, MA. D-Factor labeled with 125I 
was incubated with 2 units of endoglycosidase F
for 18 h at 37°C in reaction mixtures consisting of 
0.1 M sodium phosphate buffer, pH 6.1, 50 mM 
EDTA, 1% Nonidet P-40, 0.5% SDS and 0.5% 
2-mercaptoethanol. The 1251-labeled D-factor was 
treated with 2.5 pg of endoglycosidase H for 18 h 
at 37°C in a reaction mixture consisting of 
500 mM sodium citrate buffer, pH 6.0, 0.5% SDS 
and 0.5% 2-mercaptoethanol. 
2.8. Anti-D-factor antiserum 
Antiserum was prepared by immunizing a rabbit 
with D-factor partially purified from the CM of L 
cells as in [ll]. 
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3. RESULTS 
3.1. Purification of D-factor 
D-Factor was purified from CM of Ehrlich 
ascites tumor cells by a similar method to that used 
for purification of D-factor from CM of L cells. A 
summary of the purification is shown in table 1. D- 
Factor from Ehrlich cells and D-factor from L cells 
were eluted in similar positions from a phenyl- 
Sepharose column and a PBondapak Cl8 column 
on reverse-phase HPLC. On gel filtration of these 
preparations, the main D-factor activity from 
Ehrlich cells was eluted in fractions corresponding 
to M, 40000-50000 (fig.l), whereas the D-factor 
from L cells was eluted in fractions corresponding 
to M, 50000-70000 [6,7]. A minor fraction of ac- 
tivity of D-factor of M, 25 000 was found in a crude 
preparation from Ehrlich cells, but this activity 
was lost during subsequent purification. Aliquots 
of fractions from the high performance gel filtra- 
tion column of TSK G3OOOSW (fig.2) were 
radioiodinated and analyzed by SDS-polyac- 
rylamide gel electrophoresis and autoradiography. 
Fraction 64 gave two bands of contaminating 
material, but fractions 65 and 66 each gave a single 
band of material of A4, 40000-50000 that coin- 
cided with the biological activity (not shown). 
Results on the induction of phagocytic activity of 
Ml cells by purified D-factor are shown in fig.3. 
Assuming that the D-factor has an MI of 45000, it 
was half-maximally active at 2 x lo-” M. Even at 
5 x 10e9 M (11200 U/ml) it did not induce colony 
formation of macrophages or granulocytes from 
normal bone marrow. 
3.2. Effect of glycosidase treatment of D-factor 
CM of Ehrlich cells was applied to a column of 
Con A-Sepharose (Pharmacia) as in [6,13]. Half 
the D-factor activity was adsorbed to the column 
and could be eluted with methyl-cu-D- 
glucopyranoside. Therefore, D-factor from 
Ehrlich cells, like that from L cells, contains car- 
bohydrate. To determine the nature of the car- 
bohydrate and iI4, of the deglycosylated D-factor, 
we treated the purified radiolabeled D-factor with 
endoglycosidases in the presence of SDS and 
2-mercaptoethanol. Treatment with endo-P-N- 
acetylglucosaminidase F, but not endo-@& 
acetylglucosaminidase H, reduced the MI of the D- 
factor from 45000 to 24000 (fig.4). Treatment of 
the D-factor with 2-mercaptoethanol resulted in 
loss of biological activity, but no change in its Mr 
occurred. Therefore D-factor is a glycoprotein that 
contains internal disulfide bonds but not subunits. 
3.3. Antigenicity of D-factors 
We prepared antiserum against partially purified 
D-factor from L cells. The antiserum almost com- 
pletely neutralized the D-factor activity in mouse 
endotoxin serum and CM from L cells, embryo 
cells, lung tissue and spleen cells stimulated with 
Table 1 
Purification of D-factor from Ehrlich cell-conditioned medium 
Step D-factora Protein Specific Purification Yield 
(U x 10-q activity (-fold) Vs) 
(U/mg) 
CM (168 liters) 
Hollow fiber 
DEAE-cellulose 
Ultrogel AcA 44 
Phenyl-Sepharose 
PBondapak Cls (1st) 
PBondapak CIS (2nd) 
TSK G3OOOSW 
16488 5.2 g 3.2 x lo3 1 100 
7304 2.3 g 3.2 x 10’ 1 44.3 
6438 916 mg 7.0 x lo3 2 39.0 
3715 326 mg 1.1 x 104 4 22.5 
2055 28 mg 7.3 x 1O‘l 23 12.5 
1848 4 mg 4.8 x lo5 149 11.0 
1135 422 Pg 2.7 x lo6 843 6.9 
1104 24 rg 4.5 x 10’ 14200 6.7 
a 50 units were defined as the activity inducing 50% of phagocytic cells in 1 ml of 
‘Ml cell culture 
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Fraction No 
Fig. 1. Gel filtration of D-factor from Ehrlich cells. Run- 
through fractions from the DEAE-cellulose column were 
concentrated and applied to an Ultrogel AcA 44 column. 
Fractions were assayed for D-factor activity (0). 
Absorbance at 280 nm (-). Bovine serum albumin 
(68 kDa), ovalbumin (45 kDa) and chymotrypsinogen A
Fig.3. Induction of phagocytic activity in Ml cells by 
purified D-factor. Ml cells were incubated for 2 days 
with various concentrations of D-factor from the TSK 
G3OOOSW column and then their phagocytic activity for 
polystyrene latex particles was assayed. 
(25 kDa) were used as marker proteins. K, kDa. 123 
Frachon No 
Fig.2. High-performance gel filtration chromatography 
of D-factor on TSK G3OOOSW. Active fractions from 
the reverse-phase HPLC step were applied to a TSK 
G3OOOSW column (Toyo Soda, Tokyo) and eluted with 
45% acetonitrile containing 0.1% trifluoroacetic acid as 
in [6]. (M) D-Factor activity, (-) absorbance at 
280 nm. 
Con A [ll]. However, it did not affect the D- 
factor activity of A4, 20000-25000 in CM of 
peritoneal macrophages or differentiated Ml cells 
[12]. As shown in fig.5, D-factor activity in CM of 
Ehrlich cells was completely suppressed by the an- 
05 1 2 4 6 
D-factor (nglml ) 
-Origin 
-93K 
-68K 
-45K 
--31K 
Fig.4. SDS-polyacrylamide gel electrophoresis of “‘I- 
labeled D-factor treated with glycosidase. (1) Untreated 
and without 2-mercaptoethanol, (2) treated with endo-& 
N-acetylglucosaminidase F, (3) treated with endo-P-N- 
acetylglucosaminidase H. The molecular mass markers 
used were: phosphorylase B (93 kDa), bovine serum 
albumin (68 kDa), ovalbumin (45 kDa), carbonic 
anhydrase (31 kDa), trypsin inhibitor (22 kDa) and 
lysozyme (14 kDa). 
tiserum. Results with CM of L cells and 
macrophages are also shown. At 1: 20 dilution, the 
antiserum completely suppressed D-factor activity 
in a fraction corresponding to Mr 25000 obtained 
by gel filtration of CM of Ehrlich cells (see fig.1). 
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AntIserum (X) 
Fig.5. Antigenicity of D-factors. CM of Ehrlich cells 
(0), L cells (0) and peritoneal macrophages (A) were 
treated with various concentrations of antiserum to D- 
factor from L cells at room temperature for 30 min. 
Then D-factor activity was assayed by measuring 
induction of phagocytic activity of Ml cells. Values are 
percentages of the activity of untreated controls. 
4. DISCUSSION 
A factor inducing differentiation of mouse 
myeloid leukemic Ml cells has been purified to 
homogeneity from conditioned medium of mouse 
Ehrlich ascites tumor cells. The D-factor was half- 
maximally active at 2 x lo-” M. Even at 5 x 
10e9 M (11200 U/ml) it did not induce colony for- 
mation of macrophages or granulocytes from nor- 
mal bone marrow. Since other purified factors 
stimulating growth and differentiation of 
hematopoietic progenitor cells, such as M-CSF [8], 
GM-CSF [ 131, G-CSF [ 141 and interleukin 3 [9], 
induced colony formation of macrophages and/or 
granulocytes at 10-11-10-‘2 M, the D-factor is 
distinct from the CSFs so far purified. It is also 
distinct from a factor (MI 24000-25000) inducing 
differentiation of the mouse myelomonocytic 
leukemia cell line WEHI3B, since the latter was 
identified as a G-CSF 1141. 
We [6] previously purified a D-factor (MI 62000) 
that is also half-maximally active at 1.7 x lo-” M 
from CM of L cells. On treatment of L cells with 
tunicamycin, the Mr of the D-factor decreased 
from 67000 to 25000, indicating that the D-factor 
contained Asn-linked oligosaccharides [7]. Here, 
we showed that the M, of the D-factor from 
Ehrlich cells was decreased from 45000 to 24000 
by treatment with endo-P-N-acetylglucosaminidase 
F, but not endo-&N-acetylglycosaminidase H. The 
endoglycosidase F cleaves glycans of both ‘high 
mannose’ and ‘complex’ types linked through 
asparagine to a protein backbone [ 151, whereas the 
endoglycosidase H cleaves only glycans of the 
‘high mannose’ type [16]. Therefore, the car- 
bohydrate moieties of the D-factor are of the Asn- 
linked ‘complex’ type. However, the carbohydrate 
moieties of D-factor are not essential for its 
biological activity, since D-factor produced in the 
presence of tunicamycin is fully active [7]. The ac- 
tivities of the D-factors from Ehrlich cells and L 
cells were both completely inhibited by treatment 
with antiserum to D-factor from L cells. These 
results suggest that the difference between the sizes 
of the D-factors from Ehrlich cells and L cells is 
due to a difference in the degrees of glycosylation 
of the same or a similar polypeptide moiety. 
Although we demonstrate carbohydrate in the 
D-factor from Ehrlich ascites tumor cells and L 
cells, authors in [17] reported that the D-factors 
(MGI-2) from Krebs ascites tumor cells may not 
contain carbohydrate, because none of them 
bound to concanavalin A, soybean agglutinin or 
wheat germ agglutin agarose columns. Nearly all 
the activity of the D-factor (95%) from L cells [6] 
and 53% of the activity of D-factor from Ehrlich 
cells bound to Con A-Sepharose. Therefore, the 
degree of glycosylation of the D-factors from 
Krebs ascites tumor cells may be lower than that of 
our preparations. 
At present, the physiological role of D-factor 
without CSF activity is unknown. Radiolabeled D- 
factor will be useful for elucidating its normal 
target cells in vivo. 
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